T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.46% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.13% |
| 5 | Technology | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Domino's
DPZ
$11.7B
| $19.4M | ﹤0.01% |
265,076
+29,938
| +13% | +$2.19M |
|
1127
Zebra Technologies
ZBRA
$17.9B
| $19.2M | ﹤0.01% |
233,822
+201,862
| +632% | +$14.7M |
|
|
ENV
1128
DELISTED
ENVESTNET, INC.
ENV
| $19.2M | ﹤0.01% |
393,400
+231,000
| +142% | +$9.35M |
|
|
B
1129
Barrick Mining
B
$67.3B
| $19.2M | ﹤0.01% |
+1,050,130
| New | +$18.2M |
|
|
LXFT
1130
DELISTED
Luxoft Holding, Inc.
LXFT
| $19.2M | ﹤0.01% |
532,659
+89,120
| +20% | +$2.8M |
|
1131
Open Text
OTEX
$5.8B
| $19.1M | ﹤0.01% |
796,348
+8,118
| +1% | +$192K |
|
1132
Oil-Dri
ODC
$1.27B
| $19.1M | ﹤0.01% |
1,249,612
+8,800
| +0.7% | +$141K |
|
|
PNNT
1133
Pennant Park Investment Corp
PNNT
$249M
| $19M | ﹤0.01% |
1,661,872
-10,500
| -0.6% | -$115K |
|
1134
Cohu
COHU
$2.76B
| $19M | ﹤0.01% |
1,778,480
+9,600
| +0.5% | +$101K |
|
1135
Snap-on
SNA
$21.1B
| $19M | ﹤0.01% |
160,401
+3,161
| +2% | +$366K |
|
|
DYAX
1136
DELISTED
DYAX CORPORATION
DYAX
| $18.9M | ﹤0.01% |
1,973,500
-14,600
| -0.7% | -$111K |
|
|
SEMG
1137
DELISTED
SEMGROUP CORPORATION
SEMG
| $18.9M | ﹤0.01% |
239,400
+47,600
| +25% | +$3.23M |
|
1138
Lindblad Expeditions
LIND
$2.24B
| $18.8M | ﹤0.01% |
1,799,600
| – | – |
|
1139
Donaldson
DCI
$11.1B
| $18.7M | ﹤0.01% |
441,242
-36,000
| -8% | -$1.5M |
|
|
CUDA
1140
DELISTED
Barracuda Networks, Inc.
CUDA
| $18.6M | ﹤0.01% |
600,369
+55,189
| +10% | +$1.58M |
|
1141
Weyco Group
WEYS
$446M
| $18.6M | ﹤0.01% |
678,320
+4,750
| +0.7% | +$126K |
|
1142
Sportsman's Warehouse
SPWH
$46M
| $18.6M | ﹤0.01% |
+2,321,760
| New | +$21.2M |
|
1143
NetApp
NTAP
$40.2B
| $18.4M | ﹤0.01% |
504,752
-80
| -0% | -$2.87K |
|
1144
Coca-Cola Europacific Partners
CCEP
$47.3B
| $18.4M | ﹤0.01% |
384,557
-154,130
| -29% | -$7.11M |
|
1145
Berkshire Hathaway Class A
BRK.A
$1.09T
| $18.2M | ﹤0.01% |
96
-13
| -12% | -$2.47M |
|
1146
Live Nation Entertainment
LYV
$43.2B
| $18.2M | ﹤0.01% |
736,700
+61,275
| +9% | +$1.38M |
|
|
BCR
1147
DELISTED
CR Bard Inc.
BCR
| $18M | ﹤0.01% |
126,094
+7,300
| +6% | +$1.04M |
|
|
KEG
1148
DELISTED
KEY ENERGY SERVICES INC
KEG
| $18M | ﹤0.01% |
1,967,590
-557,500
| -22% | -$5.1M |
|
1149
WEC Energy
WEC
$35.6B
| $17.9M | ﹤0.01% |
381,970
+20,400
| +6% | +$948K |
|
1150
BlackRock TCP Capital
TCPC
$336M
| $17.6M | ﹤0.01% |
966,425
+212,202
| +28% | +$3.57M |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.